久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

  Home>News Center>Life
         
 

Cheap AIDS pill as good as pricey brands
(Agencies)
Updated: 2004-07-03 10:21

A cheap three-in-one generic AIDS pill from India is just as good as more expensive branded medicines and should be widely used in developing countries, researchers said on Friday.

Lack of scientific evidence about the clinical effectiveness of such generic fixed-dose combinations has until now caused some international AIDS donors to refuse to fund their use.

But a team from the French national agency for AIDS research and Swiss charity Medecins sans Frontieres said Cipla's Triomune performed as well as brand drugs in the first open clinical study in a developing country.

They found that 80 percent of HIV-infected patients given the tablet twice a day had undetectable levels of virus in their blood after six months treatment.

Results of the study involving 60 patients in Cameroon, 92 percent of whom had full-blown AIDS, were published in The Lancet medical journal.

“This generic fixed-dose combination (FDC) gives results comparable to those seen in the developed world using triple-drug therapy comprising brand name drugs,” said study co-ordinator Eric Delaporte.

“It is now no longer possible to raise scientific uncertainty as an objection to the widespread utilization of FDCs in the developing countries.”

In addition to being cheaper, drugs like Triomune -- which contains GlaxoSmithKline's lamivudine, Bristol-Myers Squibb's stavudine and Boehringer Ingelheim's nevirapine -- are simpler to use since patients need to take only two pills a day.

As such, they have a major role to play in meeting the World Health Organization's goal of getting antiretrovirals to three million people in the developing world by the end of 2005, N. Kumarasamy of the YRG Centre for AIDS Research and Education in Madras wrote in a commentary accompanying the research.

Controversy remains

The WHO has judged Triomune and another Indian combination called Triviro, from Ranbaxy Laboratories, to be safe and effective under a scheme that “prequalifies” them for use.

But both products -- which use compounds still covered by patents -- remain controversial.

Washington has barred groups receiving U.S. government funds from buying them, insisting only drugs approved by the Food and Drug Administration be used.

U.S. officials and Western pharmaceutical executives argue health providers are taking a risk by using medicines which have not passed the rigorous standards of the U.S. drugs watchdog.

Worries about the quality of Indian medicines were fuelled last month when the WHO removed two Cipla products -- though not Triomune -- from its prequalification list because they had not been proven to be equivalent to the original products.

Cipla says it is collecting data from new studies which should lead to the drugs being re-instated.

In Cameroon, where drugs are subsidized by the government, the cost of one month’s Triomune is $20, compared to $35 for the equivalent brand name therapy, even after heavy discounting by big pharmaceutical companies.

Elsewhere, cost differences can vary by as much as 100 percent, according to Medecins sans Frontieres.



Jackie Chan's new film 'The Myth'
CK over the top
Stephen Chow's kong fu to hit Mainland cinemas
  Today's Top News     Top Life News
 

Stress kills workaholic academics at young age

 

   
 

Efforts urged to curb floods, drought

 

   
 

China opposes foreign interference in HK

 

   
 

Ministry battles telecom price wars

 

   
 

UK indicts three in shell-fish drownings

 

   
 

Migrant workers given classes on AIDS

 

   
  Marlon Brando dies in Los Angeles hospital
   
  Apple plans new iMac, but delays shipment until Sept
   
  Fragrance makers hook up with Hollywood stars
   
  Piano maker tunes into China's growing middle class
   
  Nation hurries to salvage undersea cultural relics
   
  Panda smokes draw a crowd
   
 
  Go to Another Section  
 
 
  Story Tools  
   
  Feature  
  Oops! Britney to do marriage again  
Advertisement
         
主站蜘蛛池模板: 中文字幕精品一区二区2021年 | 欧美日韩一区二区三区在线 | 日本欧美韩国一区二区三区 | 欧美18毛片免费看 | 免费国产成人 | 五月色婷婷综合开心网亚 | 国产日本欧美在线观看 | 国产伦精一区二区三区视频 | 欧美成人3d动漫专区 | 国产精品麻豆一区二区三区v视界 | 久久综合狠狠综合久久97色 | 精品久久久影院 | 精品一久久香蕉国产线看播放 | 亚洲国产一区二区三区四区五区 | 清纯偷拍精品视频在线观看 | 欧美色成人| 黄色三级毛片 | 久久99国产精品久久99果冻传媒 | free性欧美hd另类精品 | 亚洲国产精选 | 黄色三级网站在线观看 | 99久久99久久精品免费看子 | 娇喘嗯嗯~轻点啊视频福利 | 怡红院在线视频全部观看 | 亚洲一级毛片欧美一级说乱 | 午夜视频久久 | 99久久99久久久99精品齐 | 免费国产成人18在线观看 | 美女mm131爽爽爽免费视色 | 国内精品亚洲 | 一级毛片免费观看不卡视频 | 欧美一级毛片俄罗斯 | www.日本三级 | 巴西一级毛片 | 美女mm131爽爽爽免费视色 | 亚洲一区二区三区高清 | 久久久久爽亚洲精品 | 国产一二三区在线观看 | 国内精品成人女用 | 最新中文字幕乱码在线 | 国产情侣久久 |